Jun Guo
Impact in
- Oncology top 0.5%
- Cutaneous Melanoma Detection and Management
- Cancer Immunotherapy and Biomarkers
-
- Renal cell carcinoma treatment
Papers in
- Oncology 94
- Cutaneous Melanoma Detection and Management 60
- Cancer Immunotherapy and Biomarkers 44
-
- Renal cell carcinoma treatment 27
- Sarcoma Diagnosis and Treatment 4
- Blood properties and coagulation 3
- Co-authors
- Lu Si (80 shared papers)Zhihong Chi (61 shared papers)Xinan Sheng (69 shared papers)Chuanliang Cui (65 shared papers)Lili Mao (46 shared papers)Yan Kong (45 shared papers)Jie Dai (40 shared papers)Bixia Tang (38 shared papers)
- Journals
- Annals of Oncology (17 papers)Clinical Cancer Research (12 papers)European Journal of Cancer (9 papers)BMC Cancer (6 papers)Journal for ImmunoTherapy of Cancer (4 papers)
- Partner nations
- ChinaUnited StatesAustralia
In The Last Decade
Jun Guo
174 papers receiving 7.2k citations
Jun Guo's Hit Papers
Peers
Comparison fields: 5 of 97
- Oncology 3.3k
- Pulmonary and Respiratory Medicine 1.9k
- Molecular Biology 1.6k
- Cancer Research 332
- Drug Discovery 4
Countries citing papers authored by Jun Guo
This map shows the geographic impact of Jun Guo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jun Guo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jun Guo more than expected).
Fields of papers citing papers by Jun Guo
This network shows the impact of papers produced by Jun Guo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jun Guo. The network helps show where Jun Guo may publish in the future.
Co-authors
The 25 scholars most cited alongside Jun Guo, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 176 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Pazopanib versus Sunitinib in Metastatic Renal-Cell Carcinoma Hit paper breakdown → | 2013 | 1585 |
| 2 | 2011 | 305 | |
| 3 | 2019 | 243 | |
| 4 | Open-label, Multicenter, Phase II Study of RC48-ADC, a HER2-Targeting Antibody–Drug Conjugate, in Patients with Locally Advanced or Metastatic Urothelial Carcinoma Hit paper breakdown → | 2020 | 241 |
| 5 | 2011 | 206 | |
| 6 | 2018 | 163 | |
| 7 | 2017 | 149 | |
| 8 | 2019 | 149 | |
| 9 | 2013 | 146 | |
| 10 | 2021 | 143 | |
| 11 | 2020 | 138 | |
| 12 | 2019 | 131 | |
| 13 | 2016 | 124 | |
| 14 | Efficacy and Safety of Disitamab Vedotin in Patients With Human Epidermal Growth Factor Receptor 2–Positive Locally Advanced or Metastatic Urothelial Carcinoma: A Combined Analysis of Two Phase II Clinical Trials Hit paper breakdown → | 2023 | 122 |
| 15 | 2020 | 120 | |
| 16 | 2021 | 119 | |
| 17 | 2019 | 114 | |
| 18 | 2013 | 92 | |
| 19 | 2017 | 85 | |
| 20 | 2019 | 83 |
About Jun Guo
Jun Guo is a scholar working on Oncology, Pulmonary and Respiratory Medicine, Molecular Biology, Ophthalmology and Surgery, having authored 176 papers that have together received 7.3k indexed citations. Recurring topics across this work include Cutaneous Melanoma Detection and Management (60 papers), Cancer Immunotherapy and Biomarkers (44 papers), Melanoma and MAPK Pathways (33 papers), Renal cell carcinoma treatment (27 papers), Bladder and Urothelial Cancer Treatments (6 papers), Sarcoma Diagnosis and Treatment (4 papers), PI3K/AKT/mTOR signaling in cancer (3 papers) and Blood properties and coagulation (3 papers). The work is most often cited by research in Oncology (3.3k citations), Pulmonary and Respiratory Medicine (1.9k citations), Molecular Biology (1.6k citations), Cancer Research (332 citations) and Drug Discovery (4 citations). Jun Guo has collaborated with scholars based in China, United States and Australia. Frequent co-authors include Lu Si, Zhihong Chi, Xinan Sheng, Chuanliang Cui, Lili Mao, Yan Kong, Jie Dai, Bixia Tang, Bin Lian and Siming Li. Their work appears in journals such as Annals of Oncology, Clinical Cancer Research, European Journal of Cancer, BMC Cancer and Journal for ImmunoTherapy of Cancer.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.